Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 23, 2024

SELL
$73.27 - $83.09 $32,971 - $37,390
-450 Reduced 10.39%
3,880 $314,000
Q3 2023

Oct 17, 2023

SELL
$73.94 - $80.67 $37,709 - $41,141
-510 Reduced 10.54%
4,330 $324,000
Q2 2023

Aug 07, 2023

BUY
$76.01 - $86.7 $367,888 - $419,628
4,840 New
4,840 $373,000
Q4 2022

Feb 09, 2023

BUY
$62.32 - $89.47 $150,814 - $216,517
2,420 New
2,420 $207,000
Q4 2020

Feb 12, 2021

SELL
$56.65 - $64.55 $264,555 - $301,448
-4,670 Closed
0 $0
Q3 2020

Oct 15, 2020

BUY
$62.1 - $78.08 $13,041 - $16,396
210 Added 4.71%
4,670 $295,000
Q2 2020

Aug 07, 2020

BUY
$72.34 - $84.0 $33,276 - $38,640
460 Added 11.5%
4,460 $343,000
Q1 2020

Jun 10, 2020

BUY
$62.63 - $80.22 $250,520 - $320,880
4,000 New
4,000 $299,000
Q3 2019

Oct 18, 2019

SELL
$62.51 - $69.0 $201,594 - $222,525
-3,225 Closed
0 $0
Q1 2019

Apr 25, 2019

BUY
$62.53 - $70.05 $201,659 - $225,911
3,225 New
3,225 $210,000
Q4 2018

Jan 15, 2019

SELL
$60.54 - $79.0 $1.43 Million - $1.87 Million
-23,655 Closed
0 $0
Q3 2018

Oct 17, 2018

BUY
$71.28 - $78.92 $462,607 - $512,190
6,490 Added 37.81%
23,655 $1.83 Million
Q2 2018

Jul 27, 2018

BUY
$64.88 - $75.68 $200,479 - $233,851
3,090 Added 21.95%
17,165 $1.22 Million
Q1 2018

Apr 16, 2018

BUY
$72.84 - $88.8 $214,878 - $261,960
2,950 Added 26.52%
14,075 $1.06 Million
Q4 2017

Jan 17, 2018

BUY
$71.15 - $83.52 $152,261 - $178,732
2,140 Added 23.82%
11,125 $797,000
Q3 2017

Nov 17, 2017

BUY
$72.11 - $85.47 $206,234 - $244,444
2,860 Added 46.69%
8,985 $728,000
Q2 2017

Aug 10, 2017

BUY
N/A
6,125
6,125 $434,000

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $110B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Coastline Trust CO Portfolio

Follow Coastline Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Coastline Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Coastline Trust CO with notifications on news.